Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)
Status:
Unknown status
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The objective of this randomized placebo-controlled Phase 2 study is to evaluate prophylactic
effects of dexamethasone for fatigue and malaise (weakness, lethargy, malaise) resulting from
regorafenib treatment, as well as to assess treatment continuation of regorafenib.